tiprankstipranks
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
UK Market

Circassia Pharmaceuticals (NIOX) Income Statement

Compare
10 Followers

Circassia Pharmaceuticals Income Statement

Last quarter (Q2 2024), Circassia Pharmaceuticals's total revenue was £21.00M, an increase of 123.40% from the same quarter last year. In Q2, Circassia Pharmaceuticals's net income was £4.40M. See Circassia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
£ 36.80M£ 31.30M£ 27.90M£ 23.90M£ 34.60M
Gross Profit
£ 26.50M£ 22.20M£ 19.00M£ 16.30M£ 25.50M
Operating Expenses
£ 21.90M£ 20.40M£ 22.60M£ 33.60M£ 53.20M
Depreciation and Amortization
£ 4.40M£ 4.60M£ 4.90M£ 9.00M£ 12.60M
EBITDA
£ 8.70M£ 15.40M£ 3.10M£ -9.10M£ -12.10M
Operating Income
£ 4.60M£ 1.80M£ -4.30M£ -17.30M£ -18.50M
Other Income/Expenses
£ -500.00K£ 8.70M£ 2.20M£ -1.10M£ -9.10M
Pretax Income
£ 4.10M£ 10.50M£ -2.10M£ -18.40M£ -27.60M
Net Income
£ 10.70M£ 16.10M£ 3.60M£ -33.50M£ -16.80M
Per Share Metrics
£ ―£ ―£ ―£ ―£ ―
Basic EPS
£ 0.03£ 0.04£ 0.01£ -0.09£ -0.04
Diluted EPS
£ 0.02£ 0.04£ 0.01£ -0.09£ -0.04
Weighted Average Shares Outstanding
420.21M 419.20M 412.60M 381.86M 373.70M
Weighted Average Shares Outstanding (Diluted)
449.28M 443.00M 435.83M 381.86M 373.70M
Currency in GBP

Circassia Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis